Feasibility of multimodal intraoperative neurophysiological monitoring for extramedullary spinal cord tumor surgery in elderly patients.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
08 2023
Historique:
received: 03 02 2023
accepted: 13 06 2023
medline: 9 8 2023
pubmed: 25 6 2023
entrez: 24 6 2023
Statut: ppublish

Résumé

Extramedullary spinal cord tumors (EMSCTs) are mostly benign tumors which are increasingly diagnosed and operatively treated in the elderly. While there are hints that multimodal intraoperative neurophysiological monitoring (IONM) could be influenced by age and age-related comorbidities, no study has ever systematically evaluated its feasibility and value for EMSCT surgery in elderly patients. We retrospectively evaluated all patients with microsurgical EMSCT resection under continuous multimodal IONM with SSEPs, MEPs and electromyography between 2016 and 2020. Epidemiological, clinical, imaging and operative/IONM records as well as detailed individual outcomes were analyzed and compared for the cohort < / ≥ 65 years. Mean age was 45 years in cohort < 65 years (n = 109) and 76 years in cohort ≥ 65 years (n = 64), while baseline/operative characteristics did not significantly differ. Mean baseline SSEPs' latencies (left-right average) were significantly higher in the cohort ≥ 65 years for both median (20.9 ms vs. 22.1 ms; p < 0.01) and tibial nerve (42.9 ms vs. 46.1 ms; p < 0.01) without significant differences for SSEPs' amplitudes. Stimulation intensity to elicit intraoperative MEPs was significantly higher in the cohort ≥ 65 years (surrogate-marker: left-right-averaged quotient ID1-muscle/abductor-hallucis-muscle; 1.6 vs. 2.1; p < 0.001). Intraoperatively, SSEP and MEP monitoring were feasible in 99%/100% and 99%/98% for the cohort < / ≥ 65 years without significant differences in rates for significant IONM changes during surgery or postoperatively new sensorimotor deficits. Sensitivity of IONM was 29%/43%, specificity 99%/98%, positive and negative predictive values 67%/75% and 95%/93% for the cohort < / ≥ 65 years. Overall, age was no risk factor for IONM feasibility or rate of significant IONM changes. Multimodal IONM is feasible/reliable for EMSCT surgery in elderly patients. An age-related prolongation of SSEPs' latencies and demand for higher stimulation intensities for MEPs' elicitation has to be considered.

Sections du résumé

BACKGROUND/PURPOSE
Extramedullary spinal cord tumors (EMSCTs) are mostly benign tumors which are increasingly diagnosed and operatively treated in the elderly. While there are hints that multimodal intraoperative neurophysiological monitoring (IONM) could be influenced by age and age-related comorbidities, no study has ever systematically evaluated its feasibility and value for EMSCT surgery in elderly patients.
METHODS
We retrospectively evaluated all patients with microsurgical EMSCT resection under continuous multimodal IONM with SSEPs, MEPs and electromyography between 2016 and 2020. Epidemiological, clinical, imaging and operative/IONM records as well as detailed individual outcomes were analyzed and compared for the cohort < / ≥ 65 years.
RESULTS
Mean age was 45 years in cohort < 65 years (n = 109) and 76 years in cohort ≥ 65 years (n = 64), while baseline/operative characteristics did not significantly differ. Mean baseline SSEPs' latencies (left-right average) were significantly higher in the cohort ≥ 65 years for both median (20.9 ms vs. 22.1 ms; p < 0.01) and tibial nerve (42.9 ms vs. 46.1 ms; p < 0.01) without significant differences for SSEPs' amplitudes. Stimulation intensity to elicit intraoperative MEPs was significantly higher in the cohort ≥ 65 years (surrogate-marker: left-right-averaged quotient ID1-muscle/abductor-hallucis-muscle; 1.6 vs. 2.1; p < 0.001). Intraoperatively, SSEP and MEP monitoring were feasible in 99%/100% and 99%/98% for the cohort < / ≥ 65 years without significant differences in rates for significant IONM changes during surgery or postoperatively new sensorimotor deficits. Sensitivity of IONM was 29%/43%, specificity 99%/98%, positive and negative predictive values 67%/75% and 95%/93% for the cohort < / ≥ 65 years. Overall, age was no risk factor for IONM feasibility or rate of significant IONM changes.
DISCUSSION
Multimodal IONM is feasible/reliable for EMSCT surgery in elderly patients. An age-related prolongation of SSEPs' latencies and demand for higher stimulation intensities for MEPs' elicitation has to be considered.

Identifiants

pubmed: 37355475
doi: 10.1007/s00701-023-05682-8
pii: 10.1007/s00701-023-05682-8
pmc: PMC10409671
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2089-2099

Informations de copyright

© 2023. The Author(s).

Références

World Neurosurg. 2019 May;125:498-510.e2
pubmed: 30659972
J Neurosurg. 1990 Apr;72(4):523-32
pubmed: 2319309
Neurochirurgie. 2021 Apr;67(2):112-118
pubmed: 33068594
Front Hum Neurosci. 2019 Jun 04;13:185
pubmed: 31214003
World Neurosurg. 2021 Mar;147:e516-e523
pubmed: 33383201
Front Neurol. 2020 Dec 18;11:598619
pubmed: 33391161
Acta Neurochir (Wien). 2015 May;157(5):819-30
pubmed: 25514869
Neurosurgery. 2006 Jun;58(6):1129-43; discussion 1129-43
pubmed: 16723892
Anesth Analg. 2010 Aug;111(2):421-5
pubmed: 20529980
Brain. 2010 Oct;133(10):2838-44
pubmed: 20928945
Spine (Phila Pa 1976). 1996 Mar 15;21(6):741-9
pubmed: 8882698
J Neurol. 1998 May;245(5):256-61
pubmed: 9617705
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
J Spinal Disord. 1991 Sep;4(3):286-95
pubmed: 1802159
Clin Neurophysiol. 2008 Feb;119(2):248-64
pubmed: 18053764
J Am Med Assoc. 1958 Jan 4;166(1):23-8
pubmed: 13491305
Global Spine J. 2022 Nov 21;:21925682221139822
pubmed: 36411068
J Korean Neurosurg Soc. 2021 Jan;64(1):78-87
pubmed: 33355842
Global Spine J. 2023 May;13(4):961-969
pubmed: 34011196
J Neurosurg Spine. 2019 Mar 1;:1-11
pubmed: 30835707
Clin Neurol Neurosurg. 2015 Mar;130:140-9
pubmed: 25618840
Electroencephalogr Clin Neurophysiol. 1983 Jun;55(6):619-36
pubmed: 6189692
J Neurosurg Spine. 2011 Jun;14(6):748-53
pubmed: 21438657
J Clin Neurophysiol. 2018 Sep;35(5):426-430
pubmed: 29933262
Electroencephalogr Clin Neurophysiol. 1991 Jun;81(3):209-15
pubmed: 1710970
Neurosurg Rev. 2019 Jun;42(2):371-388
pubmed: 29455369
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Clin Neurophysiol. 2007 Jun;24(3):281-5
pubmed: 17545833

Auteurs

Sebastian Siller (S)

Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. Sebastian.Siller@med.uni-muenchen.de.

Akela Sixta (A)

Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Joerg-Christian Tonn (JC)

Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Andrea Szelenyi (A)

Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH